康利, 芭芭拉·A.

Barbara A. Conley, MD, a medical oncologist, received her MD from Michigan State University. Until July 2017 she was Associate Director, Cancer Diagnosis Program, Division of Cancer Treatment & Diagnosis, National Cancer Institute (NCI), and now serves as a consultant. Her work focuses on exploring the clinical utility and clinical use of diagnostics for clinical trials. She led two NCI precision medicine initiatives – the Exceptional Responders initiative, which uses nucleic acid sequencing on tissues from patients who had remarkable responses to systemic treatments to which few patients respond, and the NCI MATCH (Molecular Analysis for Therapy Choice) trial, an umbrella basket trial in patients with refractory solid tumors and lymphomas, which screens patients for actionable mutations and assigns appropriate targeted treatment. NCI-MATCH opened in August 2015 through the National Clinical Trials Network. Her previous positions at NCI include Chief of the Diagnostics Research Branch, Senior Investigator in the Cancer Investigations Branch, both in the Division of Cancer Treatment and Diagnosis, and Chief, Aerodigestive Cancers Section, Center for Cancer Research. Positions outside NCI include Associate Professor of Medicine at University of Maryland and Chief, Division of Hematology and Oncology, Department of Medicine, Michigan State University.